Brenntag SE (BNTGF)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	8,919	8,652	13,581	9,861	13,983	11,971
Market Cap Growth	-23.53%	-36.29%	37.73%	-29.48%	16.81%	42.41%
Enterprise Value	12,078	10,683	15,971	12,379	16,362	13,948
Last Close Price	65.00	57.25	86.74	61.28	80.38	75.89
PE Ratio	15.59	15.59	17.19	10.41	27.43	20.98
PS Ratio	0.51	0.52	0.73	0.48	0.86	0.83
PB Ratio	1.73	1.76	2.82	1.92	3.08	2.71
P/TBV Ratio	10.51	12.26	16.79	7.14	22.14	16.00
P/FCF Ratio	14.47	14.81	9.15	13.38	64.95	9.60
P/OCF Ratio	9.16	9.22	7.38	9.64	31.64	8.03
EV/Sales Ratio	0.64	0.64	0.86	0.60	1.00	0.97
EV/EBITDA Ratio	8.08	9.16	11.10	7.33	14.99	13.11
EV/EBIT Ratio	11.89	11.68	13.39	8.47	18.49	16.28
EV/FCF Ratio	19.59	18.28	10.76	16.80	76.00	11.18
Debt / Equity Ratio	0.73	0.75	0.58	0.65	0.70	0.57
Debt / EBITDA Ratio	2.67	2.77	1.74	1.80	2.58	2.10
Debt / FCF Ratio	6.06	6.30	1.87	4.49	14.66	2.03
Asset Turnover	1.46	1.48	1.55	1.80	1.57	1.41
Inventory Turnover	8.26	8.44	8.11	8.90	8.60	8.28
Quick Ratio	1.01	0.97	1.04	1.25	0.92	1.20
Current Ratio	1.49	1.46	1.53	1.83	1.41	1.69
Return on Equity (ROE)	11.52%	11.92%	15.75%	20.52%	12.13%	13.18%
Return on Assets (ROA)	4.92%	5.02%	6.21%	7.92%	5.30%	5.24%
Return on Capital (ROIC)	7.19%	7.27%	9.13%	11.65%	7.81%	7.40%
Return on Capital Employed (ROCE)	10.80%	10.80%	14.70%	16.80%	11.70%	11.60%
Earnings Yield	6.41%	6.42%	5.82%	9.61%	3.65%	4.77%
FCF Yield	6.91%	6.75%	10.93%	7.47%	1.54%	10.42%
Dividend Yield	3.65%	3.80%	2.68%	3.49%	2.05%	2.18%
Payout Ratio	57.29%	56.55%	42.62%	25.26%	46.53%	41.39%
Buyback Yield / Dilution	3.09%	4.24%	2.20%	0.26%	-0.26%	-
Total Shareholder Return	6.73%	8.03%	4.88%	3.75%	1.79%	2.18%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.